Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Contrast media & molecular imaging - 1 Jan 2020

Li Zongfang, Zhao Wei, He Bo, Koh Tong San, Li Yanxi, Zeng Yizhen, Zhang Zhuo, Zhang Jingzhong, Hou Zujun

Abstract excerpt

Previous studies using contrast-enhanced imaging for glioma isocitrate dehydrogenase (IDH) mutation assessment showed promising yet inconsistent results, and this study attempts to explore this problem by using an advanced tracer kinetic model, the distributed parameter model (DP). Fifty-five patients with glioma examined using dynamic contrast-enhanced imaging sequence at a 3.0 T scanner were retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Contrast Media

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Prognosis

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 33299387
DOI: 10.1155/2020/8843084
PMCID: PMC7704178

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.PMID 33299387Read ↗

Distributed parameter model of dynamic contrast-enhanced MRI in the identification of IDH mutation, 1p19q codeletion, and tumor cell proliferation in glioma patientsSemantic proximity Read ↗

Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.Semantic proximity Read ↗

Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.Semantic proximity Read ↗

Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.Semantic proximity Read ↗

Time-dependent diffusion MRI-based microstructural mapping for predicting IDH mutation status in glioma: A multicenter study.Semantic proximity Read ↗

A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.Semantic proximity Read ↗

A novel MRI diffusion metric 'slow diffusion coefficient' (SDC) for diagnosing isocitrate dehydrogenase (IDH) genotype in diffuse gliomas: initial promising results.Semantic proximity Read ↗

Association of dynamic susceptibility contrast- and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas: A retrospective study.Semantic proximity Read ↗

A three-component multi-b-value diffusion-weighted imaging might be a useful biomarker for detecting microstructural features in gliomas with differences in malignancy and IDH-1 mutation status.Semantic proximity Read ↗

Dynamic 18F-FDopa PET Imaging for Newly-diagnosed Gliomas: Is a Semi-quantitative Model Sufficient?Semantic proximity Read ↗

Magnetic resonance diffusion-derived vessel density (DDVD) as a valuable tissue perfusion biomarker for isocitrate dehydrogenase genotyping in diffuse gliomas.Semantic proximity Read ↗

Two Diffusion Kurtosis Imaging Post-processing Methods for Differentiating Glioma Grades, IDH Mutation Statuses, and HeterogeneitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.